The Effect of inotropes and vasopressors on mortality: A meta-analysis of randomized clinical trials

British Journal of Anaesthesia

Volumn 115, Issue 5, 2015, Pages 656-675

  Belletti, A ^a   Castro, M L ^b   Silvetti, S ^a   Greco, T ^a,c   Biondi Zoccai, G ^d   Pasin, L ^a   Zangrillo, A ^a,e   Landoni, G ^a,e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b HOSPITAL DE SANTA MARTA   (Portugal)

^c UNIVERSITY OF MILAN   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

cardiotonic agents; heart failure; low cardiac output syndrome; shock; vasoconstrictor agents

Indexed keywords

HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEVOSIMENDAN; CARDIOTONIC AGENT; VASOCONSTRICTOR AGENT;

ANTIHYPERTENSIVE THERAPY; DRUG FATALITY; HEART SURGERY; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SURVIVAL; SYSTEMATIC REVIEW; VASOPLEGIA; CRITICAL ILLNESS; HEART FAILURE; MORTALITY;

CARDIOTONIC AGENTS; CRITICAL ILLNESS; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASOCONSTRICTOR AGENTS;

EID: 84946151253     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev284     Document Type: Review

References (211)

1. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013; 369: 1726-34
2. Fellahi JL, Fischer MO, Daccache G, Gerard JL, Hanouz JL. Positive inotropic agents in myocardial ischemia-reperfusion injury: a benefit/risk analysis. Anesthesiology. 2013; 118: 1460-5
3. Bangash MN, Kong ML, Pearse RM. Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol. 2012; 165: 2015-33
4. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009; 24: 293-316
5. Schmittinger CA, Torgersen C, Luckner G, Schröder DC, Lorenz I, Dünser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med. 2012; 38: 950-8
6. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991; 325: 1468-75
7. The Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. Lancet. 1990; 336: 1-6. Erratum in Lancet. 1990; 336: 698
8. Cohn JN, Goldstein SO, Greenberg BH, et al A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med. 1998; 339: 1810-6
9. Mebazaa A, Parissis J, Porcher R, et al. Short-Term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med. 2011; 37: 290-301
10. AbrahamWT, Adams KF, FonarowGC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005; 46: 57-64
11. Thackray S, Easthaugh J, Freemantle N, Cleland JG. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-A meta-regression analysis. Eur J Heart Fail. 2002; 4: 515-29
12. Nielsen DV, Hansen MK, Johnsen SP, Hansen M, Hindsholm K, Jakobsen CJ. Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a propensity score-matched analysis. Anesthesiology. 2014; 120: 1098-108
13. Shahin J, DeVarennes B, Tse CW, Amarica DA, Dial S. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care. 2011; 15: R162
14. Landoni G, Biondi-Zoccai G, Greco M, et al. Effects of levosimendan on mortality and hospitalization A meta-Analysis of randomized controlled studies. Crit Care Med. 2012; 40: 634-46
15. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J. 2009; 339: b2700
16. Greco T, Zangrillo A, Biondi-Zoccai G, Landoni G. Meta-Analysis: pitfalls and hints. Heart Lung Vessel. 2013; 5: 219-25
17. Abacilar AF, Dogan OF. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg Forum. 2013; 16: E287-94
18. Abid S, Jafri W, Hamid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial. Am J Gastroenterol. 2009; 104: 617-23
19. Adamopoulos S, Parissis JT, Iliodromitis EK, et al. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol. 2006; 98: 102-6
20. Adluri RK, Singh AV, Skoyles J, et al. The effect of fenoldopam and dopexamine on hepatic blood flowand hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg. 2009; 35: 988-94
21. Altenberger J, Parissis JT, Costard-Jaeckle A, et al. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial. Eur J Heart Fail. 2014; 16: 898-906
22. Amar D, Roistacher N, Burt ME, et al. Effects of diltiazemversus digoxin on dysrhythmias and cardiac function after pneumonectomy. Ann Thorac Surg. 1997; 63: 1374-81
23. Arbeus M, Axelsson B, Friberg O, Magnuson A, Bodin L, Hultman J. Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study. J Cardiothorac Vasc Anesth. 2009; 23: 48-53
24. Asaad OM, Hanafy MS. Levosimendan s effect on coronary artery grafts blood flow in patients with left ventricular dysfunction, assessment by transit flow meter. Egypt J Anaesth. 2011; 27: 45-53
25. Bach F, Silomon M, Grundmann U, Stürner J, Graeter T, Larsen R. [Effects of dopexamine on splanchnic perfusion in cardiac surgery]. Anaesthesist. 1999; 48: 713-7. [Article in German
26. Bach F, Grundmann U, Bauer M, et al. Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia. Acta Anaesthesiol Scand. 2002; 46: 1227-35
27. Bader FM, Gilbert EM, Mehta NA, Bristow MR. Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure. Congest Heart Fail. 2010; 16: 265-70
28. Badner NH, Murkin JM, Shannon NA. An amrinone bolus prior to weaning from cardiopulmonary bypass improves cardiac function in mitral valve surgery patients. J Cardiothorac Vasc Anesth. 1994; 8: 410-4
29. Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med. 1994; 120: 744-7
30. Barisin S, Husedzinovic I, Sonicki Z, Bradic N, Barisin A, Tonkovic D. Levosimendan in off-pump coronary artery bypass: a four-Times masked controlled study. J Cardiovasc Pharmacol. 2004; 44: 703-8
31. Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C. Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2014; 28: 586-94
32. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Lowdose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000; 356: 2139-43
33. Berendes E, Möllhoff T, Van Aken H, et al. Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Analg. 1997; 84: 950-7
34. Berger R, Moertl D, Huelsmann M, et al. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure. Eur J Heart Fail. 2007; 9: 202-8
35. Biancofiore G, Della Rocca G, Bindi L, et al. Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl. 2004; 10: 986-92
36. Biteker M, Duran NE, Kaya H, et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol. 2011; 100: 571-7
37. Bove T, Landoni G, Calabrò MG, et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation. 2005; 111: 3230-5
38. Brackbill ML, Stam MD, Schuller-Williams RV, Dhavle AA. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. Ann Pharmacother. 2007; 41: 427-32
39. Bragadottir G, Redfors B, Ricksten SE. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study. Crit Care Med. 2013; 41: 2328-35
40. Brienza N, Malcangi V, Dalfino L, et al A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med. 2006; 34: 707-14
41. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-Type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002; 144: 1102-8
42. Callaway CW, Hostler D, Doshi AA, et al. Usefulness of vasopressin administered with epinephrine during out-ofhospital cardiac arrest. Am J Cardiol. 2006; 98: 1316-21
43. Carcoana OV, Mathew JP, Davis E, et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial. Anesth Analg. 2003; 97: 1222-9
44. Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013; 310: 2533-43
45. Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg. 2011; 35: 430-9
46. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997; 62: 187-93
47. Couture P, Denault AY, Pellerin M, Tardif JC. Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. Can J Anaesth. 2007; 54: 509-22
48. Cowley AJ, Skene AM. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. Br Heart J. 1994; 72: 226-30
49. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-Term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002; 287: 1541-7
50. Davies SJ, Yates D, Wilson RJ. Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery. Anesth Analg. 2011; 112: 130-8
51. de Lasson L, Hansen HE, Juhl B, Paaske WP, Pedersen EB A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery. Eur J Vasc Endovasc Surg. 1995; 10: 82-90
52. de Silva HA, Pathmeswaran A, Ranasinha CD, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011; 8: e1000435
53. Dehne MG, Klein TF, Mühling J, Sablotzki A, Osmer C, Hempelmann G. Impairment of renal function after cardiopulmonary bypass is not influenced by dopexamine. Ren Fail. 2001; 23: 217-30
54. Della Rocca G, Pompei L, Costa MG, et al. Fenoldopammesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial. Anesth Analg. 2004; 99: 1604-9
55. Dentz ME, Lubarsky DA, Smith LR, et al A comparison of amrinone with sodium nitroprusside for control of hemodynamics during infrarenal abdominal aortic surgery. J Cardiothorac Vasc Anesth. 1995; 9: 486-90
56. Di Roio C, Védrinne JM, Hoen JP, et al. [Prevention of arterial hypotension during spinal anesthesia using intramuscular ephedrine in older people]. Ann Fr Anesth Reanim. 1997; 16: 483-7 [Article in French
57. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336: 525-33
58. Doolan LA, Jones EF, Kalman J, Buxton BF, Tonkin AM A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997; 11: 37-41
59. Ducros L, Vicaut E, Soleil C, et al. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans. J Emerg Med. 2011; 41: 453-9
60. DünserMW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003; 107: 2313-9
61. El-Tahan MR. Preoperative ephedrine counters hypotension with propofol anesthesia during valve surgery: a dose dependent study. Ann Card Anaesth. 2011; 14: 30-40
62. Ensinger H, Rantala A, Vogt J, Georgieff M, Takala J. Effect of dobutamine on splanchnic carbohydrate metabolism and amino acid balance after cardiac surgery. Anesthesiology. 1999; 91: 1587-95
63. Erb J, Beutlhauser T, Feldheiser A, et al. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J Int Med Res. 2014; 42: 750-64
64. Eriksson HI, Jalonen JR, Heikkinen LO, et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg. 2009; 87: 448-54
65. Ersoy O, Boysan E, Unal EU, et al. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients. Cardiovasc J Afr. 2013; 24: 260-4
66. Escorsell A, Ruiz del Arbol L, Planas R, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology. 2000; 32: 471-6
67. Feldman AM, Oren RM, AbrahamWT, et al. Low-dose oral enoximone enhances the ability to wean patients with ultraadvanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotropedependent subjects trial. Am Heart J. 2007; 154: 861-9
68. Feu F, Ruiz del Arbol L, Bañares R, Planas R, Bosch J. Doubleblind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology. 1996; 111: 1291-9
69. Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol. 2006; 98: 1641-5
70. Gårdebäck M, Settergren G. Dopexamine and dopamine in the prevention of low gastric mucosal pH following cardiopulmonary by-pass. Acta Anaesthesiol Scand. 1995; 39: 1066-70
71. GårdebäckM, Settergren G, Ohquist G, Tirén C. Effect of dopexamine on calculated low gastric intramucosal pH following valve replacement. Acta Anaesthesiol Scand. 1995; 39: 599-604
72. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol. 1999; 34: 1682-8
73. Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail. 2010; 16: 922-30
74. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med. 2008; 359: 21-30
75. Hadadzadeh M, Hosseini SH, Mostafavi Pour Manshadi SM, Naderi N, Emami Meybodi M. Effect of milrinone on short term outcome of patients with myocardial dysfunction undergoing off-pump coronary artery bypass graft: a randomized clinical trial. Acta Med Iran. 2013; 51: 681-6
76. Hamada Y, Kawachi K, Yamamoto T, et al. Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass: comparison of milrinone and amrinone. Jpn Circ J. 1999; 63: 605-9
77. Hasija S, Makhija N, Choudhury M, Hote M, Chauhan S, Kiran U. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010; 24: 230-8
78. Hayashida N, Tomoeda H, Oda T, et al. Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. Ann Thorac Surg. 1999; 68: 1661-7
79. Hong SH, Lee JM, Choi JH, Chung HS, Park JH, Park CS. Perioperative assessment of terlipressin infusion during living donor liver transplantation. J Int Med Res. 2012; 40: 225-36
80. Hou ZY, Chang MS, Chen CY, et al. Acute treatment of recentonset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone A randomized, digoxincontrolled study. Eur Heart J. 1995; 16: 521-8
81. Husebye T, Eritsland J, Müller C, et al. Levosimendan in acute heart failure following primary percutaneous coronary intervention-Treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebocontrolled study. Eur J Heart Fail. 2013; 15: 565-72
82. Husedzinović I, Barisin S, Bradić N, Barisin A, Sonicki Z, Milanović R. Levosimendan as a new strategy during offpump coronary artery bypass grafting: double-blind randomized placebo-controlled trial. Croat Med J. 2005; 46: 950-6
83. Ikonomidis I, Parissis JT, Paraskevaidis I, et al. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure. Eur J Heart Fail. 2007; 9: 1172-7
84. Innes GD, Vertesi L, Dillon EC, Metcalfe C. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation. Ann Emerg Med. 1997; 29: 126-34
85. Jacobs IG, Finn JC, Jelinek GA, Oxer HF, Thompson PL. Effect of adrenaline onsurvival in out-of-hospital cardiac arrest: Arandomised double-blind placebo-controlled trial. Resuscitation. 2011; 82: 1138-43
86. Jaffe R, Rubinshtein R, Feigenberg Z, et al. Evaluation of isoproterenol in patients undergoing resuscitation for out-ofhospital asystolic cardiac arrest (the Israel Resuscitation with Isoproterenol Study Prospective Randomized Clinical Trial). Am J Cardiol. 2004; 93: 1407-9, A9
87. Järvelä K, Maaranen P, Sisto T, Ruokonen E. Levosimendan in aortic valve surgery: cardiac performance and recovery. J Cardiothorac Vasc Anesth. 2008; 22: 693-8
88. Jebeli M, Ghazinoor M, Mandegar MH, et al. Effect of milrinone on short-Term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial. Cardiol J. 2010; 17: 73-8
89. Jia Z, Guo M, Zhang YQ, Liang HQ, Zhang LY, Song Y. Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction. Cardiology. 2014; 128: 195-201
90. Jia Z, Guo M, Zhang LY, Zhang YQ, Liang HQ, Song Y. Levosimendan and Nesiritide as a Combination Therapy in Patients With Acute Heart Failure. Am J Med Sci. 2015; 349: 398-405
91. Jo HR, Lee WK, Kim YH, et al. The effect of milrinone infusion on right ventricular function during coronary anastomosis and early outcomes in patients undergoing off-pump coronary artery bypass surgery. Korean J Anesthesiol. 2010; 59: 92-8
92. Jondeau G, Dubourg O, Delorme G, et al. Oral enoximone as a substitute for intravenous catecholamine support in endstage congestive heart failure. Eur Heart J. 1994; 15: 242-6
93. Joseph AP, Ward MR A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med. 2000; 36: 1-9
94. Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003; 42: 1944-51
95. Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001; 29: 1860-7
96. Kleber FX, Bollmann T, Borst MM, et al. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study. J Clin Pharmacol. 2009; 49: 109-15
97. Knezevic I, Poglajen G, Hrovat E, et al. The effects of levosimendan on renal function early after heart transplantation: results froma pilot randomized trial. Clin Transplant. 2014; 28: 1105-11
98. Kodalli RK, Sundar AS, Vakamudi M, et al. Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: a randomized controlled study. Ann Card Anaesth. 2013; 16: 94-9
99. Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg. 2002; 94: 824-9
100. Kurt IH, Yavuzer K, Batur MK. Short-Term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure. Heart Vessels. 2010; 25: 392-9
101. Kwak YL, Oh YJ, Shinn HK, Yoo KJ, Kim SH, Hong YW. Haemodynamic effects of a milrinone infusion without a bolus in patients undergoing off-pump coronary artery bypass graft surgery. Anaesthesia. 2004; 59: 324-31
102. Lahtinen P, Pitkänen O, Pölönen P, Turpeinen A, Kiviniemi V, Uusaro A. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med. 2011; 39: 2263-70
103. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000; 11: 97-104
104. Lee HY, Lee HJ, Lee SM, et al A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis. Korean J InternMed. 2003; 18: 161-6
105. Lee JH, Oh YJ, Shim YH, Hong YW, Yi G, Kwak YL. The effect of milrinone on the right ventricular function in patients with reduced right ventricular function undergoing offpump coronary artery bypass graft surgery. J Korean Med Sci. 2006; 21: 854-8
106. Leppikangas H, Järvelä K, Sisto T, et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth. 2011; 106: 298-304
107. Leppikangas H, Tenhunen JJ, Lindgren L, Salenius JP, Ruokonen E. Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosalarterial pCO2 gradient in abdominal aortic aneurysm surgery. Acta Anaesthesiol Scand. 2008; 52: 785-92
108. Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004; 77: 496-9
109. Lewis KP, Appadurai IR, Pierce ET, Halpern EF, Bode RH Jr. Prophylactic amrinone for weaning from cardiopulmonary bypass. Anaesthesia. 2000; 55: 627-33
110. Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail. 2007; 9: 75-82
111. Llorens P, Miró Ò, Román F, Zapater P, Carbajosa-Dalmau J, Llanos L. Efficacy of early administration of levosimendan in emergency department in patients with acute heart failure: a randomized pilot clinical trial. Emergencias. 2012; 24: 268-76
112. Lobo SM, Lobo FR, Polachini CA, et al. Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42 445141]. Crit Care. 2006; 10: R72
113. Lowes BD, Higginbotham M, Petrovich L, et al. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Am Coll Cardiol. 2000; 36: 501-8
114. Luckner G, DünserMW, Stadlbauer KH, et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care. 2006; 10: 0-00
115. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Lowdose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999; 47: 699-703
116. Malfatto G, Della Rosa F, Villani A, et al. Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. J Cardiovasc Pharmacol. 2012; 60: 450-5
117. Martín-LlahíM, Pépin MN, GuevaraM, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008; 134: 1352-9
118. Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006; 103: 2-8
119. Mavrogeni S, Giamouzis G, Papadopoulou E, et al A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure. J Card Fail. 2007; 13: 556-9
120. McGinley J, Lynch L, Hubbard K, McCoy D, Cunningham AJ. Dopexamine hydrochloride does not modify hemodynamic response or tissue oxygenation or gut permeability during abdominal aortic surgery. Can J Anaesth. 2001; 48: 238-44
121. Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002; 30: 755-62
122. Metra M, Eichhorn E, Abraham WT, et al. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009; 30: 3015-26
123. Modine T, Decoene C, Al-Ruzzeh S, et al. Dobutamine improves thoracic aortic blood flow during off-pump coronary artery bypass surgery: results of a prospective randomised controlled trial. Eur J Cardiothorac Surg. 2005; 27: 289-95
124. Moiseyev VS, Põder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002; 23: 1422-32
125. Möllhoff T, Schmidt C, Van Aken H, et al. Myocardial ischaemia in patients with impaired left ventricular function undergoing coronary artery bypass grafting-milrinone versus nifedipin. Eur J Anaesthesiol. 2002; 19: 796-802
126. Möllhoff T, Loick HM, Van Aken H, et al. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). Anesthesiology. 1999; 90: 72-80
127. Morales DL, Garrido MJ, Madigan JD, et al A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003; 75: 926-30
128. Moreau R, Asselah T, Condat B, et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut. 2002; 50: 90-4
129. Morelli A, Ertmer C, Lange M, et al. Effects of short-Term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008; 100: 494-503
130. Mukhtar A, Salah M, Aboulfetouh F, et al. The use of terlipressin during living donor liver transplantation: Effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med. 2011; 39: 1329-34
131. Nagai R, Kinugawa K, Inoue H, et al. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-shortacting β1-selective blocker landiolol with digoxin (J-Land Study). Circ J. 2013; 77: 908-16
132. Nanas JN, Tsagalou EP, Kanakakis J, et al. Long-Term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study. Chest. 2004; 125: 1198-204
133. Nieminen MS, Akkila J, Hasenfuss G, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol. 2000; 36: 1903-12
134. Nieminen MS, Cleland JG, Eha J, et al. Oral levosimendan in patients with severe chronic heart failure -The PERSIST study. Eur J Heart Fail. 2008; 10: 1246-54
135. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol. 1999; 34: 219-28
136. Okamoto Y, Nohmi T, Higa Y, Seki K, Yamashita A. Vasopressin does not raise cardiac enzymes following cardiac surgery: a randomized double-blind clinical trial. J Cardiothorac Vasc Anesth. 2015; 29: 46-51
137. Oliva F, Latini R, Politi A, et al. Intermittent 6-month lowdose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J. 1999; 138: 247-53
138. Orii R, Sugawara Y, Hayashida M, et al. Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1. Br J Anaesth. 2000; 85: 389-95
139. O-Yurvati AH, Laub GW, Sanders SP, Dullye LJ, Reibman JB, McGrath LB. Reduction in pulmonary microvascular pressure following cardiopulmonary bypass: beneficial effects of dobutamine. Int Surg. 1995; 80: 231-4
140. Ozal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005; 79: 1615-9
141. PackerM, ColucciW, Fisher L, et al. Effect of levosimendan on the short-Term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013; 1: 103-11
142. Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E. Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg. 2010; 5: 17
143. Parissis JT, Papadopoulos C, Nikolaou M, et al. Effects of levosimendan on quality of life andemotional stress in advanced heart failure patients. Cardiovasc Drugs Ther. 2007; 21: 263-8
144. Parks RW, Diamond T, McCrory DC, Johnston GW, Rowlands BJ. Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine. Br J Surg. 1994; 81: 437-9
145. Parviainen I, Ruokonen E, Takala J. Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intramucosal pH after cardiac surgery. Br J Anaesth. 1995; 74: 277-82
146. Pasqui AL, Maffei S, Di Renzo M, Pompella G, Auteri A, Puccetti L. Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure A randomized, double-blind, placebo-controlled study. Int J Cardiol. 2011; 147: 314-5
147. Premawardhena AP, de Silva CE, Fonseka MM, Gunatilake SB, de Silva HJ. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. Br Med J. 1999; 318: 1041-3
148. Ralph CJ, Tanser SJ, Macnaughton PD, Sinclair DG A randomised controlled trial investigating the effects of dopexamine on gastrointestinal function and organ dysfunction in the critically ill. Intensive Care Med. 2002; 28: 884-90
149. Reyad AR, Elkharboutly W, Wahba A, Elmorshedi M, Hasaneen NA. Effect of intraoperative dobutamine on splanchnic tissue perfusion and outcome after Whipple surgery. J Crit Care. 2013; 28: 531.e7-e15
150. Ristikankare A, Pöyhiä R, Eriksson H, Valtonen M, Leino K, Salmenperä M. Effects of levosimendan on renal function in patients undergoing coronary artery surgery. J Cardiothorac Vasc Anesth. 2012; 26: 591-5
151. Ryu HG, Jung CW, Lee HC, Cho YJ. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation. Liver Transpl. 2012; 18: 1430-9
152. SantarpinoG, Caroleo S, Onorati F, et al. Inflammatory response to cardiopulmonary bypass with enoximone or steroids in patients undergoingmyocardial revascularization: a preliminary report study. Int J Clin Pharmacol Ther. 2009; 47: 78-88
153. Sanyal AJ, Boyer T, Garcia-Tsao G, et al A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008; 134: 1360-8
154. Schmoelz M, Schelling G, Dunker M, Irlbeck M. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-Treated septic shock. J Cardiothorac Vasc Anesth. 2006; 20: 173-8
155. Seo YS, Park SY, Kim MY, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014; 60: 954-63
156. Shah B, Sharma P, Brahmbhatt A, et al. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study. Indian J Pharmacol. 2014; 46: 29-34
157. Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H. Preoperative levosimendan in ischemic mitral valve repair. Asian Cardiovasc Thorac Ann. 2013; 22: 539-45
158. Sharpe DA, Mitchel IM, Kay EA, McGoldrick JP, Munsch CM, Kay PH. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine. Perfusion. 1999; 14: 29-36
159. Sherry E, Tooley MA, Bolsin SN, Monk CR, Willcox J. Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery. Eur J Anaesthesiol. 1997; 14: 184-9
160. Shi Y, Denault AY, Couture P, Butnaru A, Carrier M, Tardif JC. Biventricular diastolic filling patterns after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2006; 131: 1080-6
161. Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol. 2006; 21: 303-7
162. Siostrzonek P, Koreny M, Delle-Karth G, Haumer M, Koller-Strametz J, Heinz G. Milrinone therapy in catecholaminedependent critically ill patients with heart failure. Acta Anaesthesiol Scand. 2000; 44: 403-9
163. Slawsky MT, Colucci WS, Gottlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation. 2000; 102: 2222-7
164. Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol. 2003; 18: 152-6
165. Song JW, Jo YY, Jun NH, Kim HK, Kwak YL. The effect of milrinone on the intraoperative hemodynamics during offpump coronary bypass surgery in patients with an elevated echocardiographic index of the ventricular filling pressure. Korean J Anesthesiol. 2011; 60: 185-91
166. Sorbello M, Morello G, Paratore A, et al. Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data. Transplant Proc. 2007; 39: 1794-6
167. Sorbello M, Morello G, Parrinello L, et al. Effect of N-Acetylcysteine (NAC) added to fenoldopam or dopamine on endtidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation. Transplant Proc. 2010; 42: 1056-60
168. Squara P, Denjean D, Godard P, Brunet F, Brusset A, Dubois C. Enoximone vs nicardipine during the early postoperative course of patients undergoing cardiac surgery A prospective study of two therapeutic strategies. Chest. 1994; 106: 52-8
169. Stanek B, Sturm B, Frey B, et al. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine. J Heart Lung Transplant. 1999; 18: 358-66
170. Stone MD, Wilson RJ, Cross J, Williams BT. Effect of adding dopexamine to intraoperative volume expansion in patients undergoing major elective abdominal surgery. Br J Anaesth. 2003; 91: 619-24
171. Svoboda P, Scheer P, Kantorová I, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012; 59: 1043-7
172. Takala J, Meier-Hellmann A, Eddleston J, Hulstaert P, Sramek V. Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study. European Multicenter Study Group on Dopexamine in Major Abdominal Surgery. Crit Care Med. 2000; 28: 3417-23
173. Taurà P, Fuster J, Mercadal J, et al. The use of beta-Adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection. J Hepatol. 2010; 52: 340-7
174. Thomas SP, Guy D, Wallace E, et al. Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. Am Heart J. 2004; 147: e3
175. TorracoA, Carrozzo R, Piemonte F, et al. Effects of levosimendan on mitochondrial function in patients with septic shock: a randomized trial. Biochimie. 2014; 102: 166-73
176. Trikas A, Antoniades C, Latsios G, et al. Long-Term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure. Eur J Heart Fail. 2006; 8: 804-9
177. Triposkiadis FK, Butler J, Karayannis G, et al. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Int J Cardiol. 2014; 172: 115-21
178. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-A pilot study. Br J Anaesth. 2006; 96: 694-700
179. Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth. 2009; 102: 198-204
180. Tse HF, Lam YM, Lau CP, Cheung BM, Kumana CR. Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation. Clin Exp Pharmacol Physiol. 2001; 28: 446-50
181. Tziakas DN, Chalikias GK, Hatzinikolaou HI, et al. Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure. Cardiovasc Drugs Ther. 2005; 19: 399-402
182. Väisänen O, Ruokonen E, Parviainen I, Bocek P, Takala J. Ranitidine or dobutamine alone or combined has no effect on gastric intramucosal-Arterial PCO(2) difference after cardiac surgery. Intensive Care Med. 2000; 26: 45-51
183. van der Maaten JM, de Vries AJ, Rietman GW, Gallandat Huet RC, De Hert SG. Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis. J Cardiothorac Vasc Anesth. 2007; 21: 357-66
184. Van Noord T, Van Gelder IC, Tieleman RG, et al. VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2001; 12: 766-9
185. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. Br Med J. 1999; 318: 1099-103
186. Woo EB, Tang AT, el-Gamel A, et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg. 2002; 22: 106-11
187. Woodhouse SP, Cox S, Boyd P, Case C, Weber M. High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation. 1995; 30: 243-9
188. Yamaura K, Okamoto H, Akiyoshi K, Irita K, Taniyama T, Takahashi S. Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2001; 15: 197-203
189. Yavuz S, Ayabakan N, Goncu MT, Ozdemir IA. Effect of combined dopamine and diltiazem on renal function after cardiac surgery. Med Sci Monit. 2002; 8: PI45-50
190. Yavuz S, Ayabakan N, Dilek K, Ozdemir A. Renal dose dopamine in open heart surgery. Does it protect renal tubular function? J Cardiovasc Surg. 2002; 43: 25-30
191. Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation. J Card Fail. 2007; 13: 417-21
192. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-Tobedside review: Inotropic drug therapy after adult cardiac surgery - A systematic literature review. Crit Care. 2005; 9: 266-79
193. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994; 330: 1717-22
194. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128: e240-327
195. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33: 1787-847
196. Silvetti S, Greco T, Di Prima AL, et al. Intermittent levosimendan improves mid-Term survival in chronic heart failure patients: meta-Analysis of randomised trials. Clin Res Cardiol. 2014; 103: 505-13
197. Felker GM, Benza RL, Chandler AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol. 2003; 41: 997-1003
198. Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol. 2001; 189: 257-65
199. Williams JB, Hernandez AF, Li S, et al. Postoperative inotrope and vasopressor use following CABG: outcome data fromthe CAPS-care study. J Card Surg. 2011; 26: 572-8
200. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358: 877-87
201. Serpa Neto A, Nassar AP Jr, Cardoso SO, et al. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-Analysis of nine randomized controlled trials. Crit Care. 2012; 16: R154
202. TollerW, Heringlake M, Guarracino F, et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol. 2015; 184: 323-36
203. Nieminen MS, Fruhwald S, Heunks LM, et al. Levosimendan: current data, clinical use and future development. Heart Lung Vessel. 2013; 5: 227-45
204. Orme RM, Perkins GD, McAuley DF, et al. An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial. Trials. 2014; 15: 199
205. Jammer I, Wickboldt N, Sander M, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015; 32: 88-105
206. Cecconi M, Corredor C, Arulkumaran N, et al. Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect ondifferent risk groups. Crit Care. 2013; 17: 209
207. Gattinoni L, Brazzi L, Pelosi P, et al A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995; 333: 1025-32
208. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345: 1368-77
209. Yealy DM, Kellum JA, Huang DT, et al A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370: 1683-93
210. Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014; 371: 1496-506
211. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goaldirected resuscitation for septic shock. N Engl J Med. 2015; 372: 1301-11